Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Steven Sun"'
Autor:
John Gerecitano, Jodi Carey, Christopher Major, Peter Johnson, Songbai Wang, Pier Luigi Zinzani, Wyndham H. Wilson, Steven Sun, Jessica Vermeulen, S. Martin Shreeve, Louis M. Staudt, Laurie H. Sehn, Michael Schaffer, Brendan P. Hodkinson, Sriram Balasubramanian
Publikováno v:
Br J Haematol
We assessed the concordance between immunohistochemistry (IHC) and gene expression profiling (GEP) for determining diffuse large B-cell lymphoma (DLBCL) cell of origin (COO) in the phase III PHOENIX trial of rituximab plus cyclophosphamide, doxorubic
Autor:
Xiaoyan Ke, Angela Howes, Mariya Salman, Lugui Qiu, Jianyong Li, Jie Jin, Xiao-Jun Huang, Daobin Zhou, Hanyun Ren, Ming Hou, Yu Hu, Yingmin Liang, Peng Wu, Junmin Li, Chunting Zhao, Yue Lv, Jingzhao Wang, Steven Sun, Jianda Hu, Jianmin Wang, Aining Sun, Ting Liu, Xiequn Chen
Publikováno v:
Cancer Medicine
In the Asia‐Pacific region, treatment options are limited for patients with relapsed/refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). Rituximab is widely used in this setting when purine analog‐based therapies are n
Autor:
Steven Sun, Mats Jerkeman, Simon Rule, Georg Hess, John Bothos, Isabelle Bence-Bruckler, Mathias Witzens-Harig, Nibedita Bandyopadhyay, Fritz Offner, Christopher Enny, Jessica Vermeulen, Dolores Caballero, Aleksandra Rizo, Shana Traina, Sriram Balasubramanian, Chiara Rusconi, Martin Dreyling, Cristina João, Seok-Goo Cho, Rodrigo Santucci Silva, Jenna D. Goldberg, Marek Trneny, Wojciech Jurczak
Mantle-cell lymphoma is an aggressive B-cell lymphoma with a poor prognosis. Both ibrutinib and temsirolimus have shown single-agent activity in patients with relapsed or refractory mantle-cell lymphoma. We undertook a phase 3 study to assess the eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97f3968cb14298604d326493927a7acf
https://ruj.uj.edu.pl/xmlui/handle/item/117399
https://ruj.uj.edu.pl/xmlui/handle/item/117399